X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (372) 372
male (358) 358
index medicus (307) 307
sildenafil (239) 239
erectile dysfunction (237) 237
sildenafil citrate (210) 210
animals (177) 177
erectile dysfunction - drug therapy (162) 162
phosphodiesterase inhibitors - therapeutic use (146) 146
urology & nephrology (142) 142
tadalafil (129) 129
middle aged (126) 126
impotence (109) 109
double-blind (105) 105
piperazines - therapeutic use (103) 103
treatment outcome (102) 102
adult (99) 99
pharmacology & pharmacy (98) 98
nitric-oxide (92) 92
piperazines - pharmacology (89) 89
men (84) 84
phosphodiesterase type-5 inhibitors (84) 84
nitric oxide (79) 79
pulmonary hypertension (79) 79
vardenafil dihydrochloride (79) 79
female (78) 78
rats (78) 78
phosphodiesterase 5 inhibitors - therapeutic use (77) 77
phosphodiesterase inhibitors - pharmacology (76) 76
aged (75) 75
vardenafil (72) 72
hypertension, pulmonary - drug therapy (69) 69
sulfones - therapeutic use (66) 66
purines (64) 64
phosphodiesterase type-5 inhibitor (63) 63
sulfones (63) 63
efficacy (62) 62
phosphodiesterase type-5 (62) 62
sulfones - pharmacology (60) 60
drug therapy (59) 59
phosphodiesterase (59) 59
phosphodiesterase inhibitors (54) 54
phosphodiesterase 5 inhibitors - pharmacology (53) 53
cyclic nucleotide phosphodiesterases, type 5 (52) 52
safety (52) 52
phosphodiesterase 5 inhibitors (51) 51
piperazines - administration & dosage (51) 51
purines - pharmacology (51) 51
care and treatment (50) 50
risk factors (49) 49
erectile dysfunction - etiology (48) 48
imidazoles - therapeutic use (48) 48
therapy (48) 48
hypertension (47) 47
cardiac & cardiovascular systems (46) 46
erectile dysfunction - physiopathology (45) 45
double-blind method (44) 44
analysis (43) 43
dose-response relationship, drug (43) 43
research (43) 43
sulfones - administration & dosage (42) 42
phosphodiesterase inhibitors - adverse effects (41) 41
vasodilator agents - therapeutic use (41) 41
medicine & public health (40) 40
phosphodiesterase inhibitors - administration & dosage (40) 40
carbolines - therapeutic use (39) 39
purines - therapeutic use (39) 39
medicine, general & internal (38) 38
oral sildenafil (38) 38
sexual dysfunction (38) 38
cyclic gmp - metabolism (37) 37
hypertension, pulmonary - physiopathology (37) 37
penile erection - drug effects (37) 37
phosphodiesterase 5 inhibitors - administration & dosage (37) 37
triazines - therapeutic use (37) 37
vasodilator agents - pharmacology (37) 37
health aspects (36) 36
expression (35) 35
time factors (35) 35
cgmp (33) 33
prevalence (33) 33
administration, oral (32) 32
drug therapy, combination (32) 32
endothelial dysfunction (32) 32
corpus cavernosum (31) 31
inhibitors (31) 31
phosphodiesterases (31) 31
piperazines - adverse effects (31) 31
endothelium (30) 30
internal medicine (30) 30
pulmonary arterial hypertension (30) 30
type-5 inhibitors (30) 30
cyclic nucleotide phosphodiesterases, type 5 - metabolism (29) 29
nitric-oxide synthase (29) 29
purines - administration & dosage (29) 29
rats, sprague-dawley (29) 29
rats, wistar (29) 29
sexual disorders (29) 29
3',5'-cyclic-gmp phosphodiesterases - antagonists & inhibitors (28) 28
benign prostatic hyperplasia (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (587) 587
Japanese (5) 5
German (3) 3
French (2) 2
Italian (2) 2
Turkish (2) 2
Chinese (1) 1
Hungarian (1) 1
Portuguese (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heart, ISSN 1355-6037, 11/2016, Volume 102, Issue 21, pp. 1750 - 1756
Journal Article
Journal Article
Journal Article
by Dang, ZC and Tang, B and Li, B and Liu, S and Ge, RL and Li, ZQ and Lu, DX
EXPERIMENTAL AND THERAPEUTIC MEDICINE, ISSN 1792-0981, 12/2019, Volume 18, Issue 6, pp. 4740 - 4746
...) inhibitors for treating PAH. Eligible published studies were collected from Embase, PubMed, The Cochrane Library and the www.clinicaltrials.gov website... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | TRIALS | prostacyclin analogues | COMBINATION THERAPY | meta-analysis | SELEXIPAG | ILOPROST | bosentan combination therapy | phosphodiesterase type 5 inhibitors | ENDOTHELIN-RECEPTOR ANTAGONIST | ORAL TREPROSTINIL | pulmonary arterial hypertension | INHALED TREPROSTINIL
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 2006, Volume 341, Issue 3, pp. 837 - 846
Journal Article